Quick Answer
SELLAS Life Sciences Group, Inc. reported Operating Income Loss of -$28.27 million for the year ending 2025.
- SELLAS Life Sciences Group, Inc. showed an increase of +10.3% in Operating Income Loss from 2024 to 2025.
- This data is from SELLAS Life Sciences Group, Inc.'s annual report (Form 10-K), filed with the SEC on March 19, 2026.
- XBRL data for this metric is available from 2011 to 2025 (14 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q2 2010: -$4.75 million | Q2 2011: -$4.62 million | Q3 2012: -$5.53 million | Q1 2013: -$6.61 million | Q2 2013: -$7.99 million | Q3 2013: -$6.89 million | Q1 2014: -$11.85 million | Q2 2014: -$15.78 million | Q3 2014: -$10.57 million | Q1 2015: -$8.91 million | Q2 2015: -$9.08 million | Q3 2015: -$8.64 million | Q1 2016: -$8.97 million | Q2 2016: -$9.29 million | Q3 2016: -$6.47 million | Q1 2017: -$5.09 million | Q2 2017: -$4.91 million | Q3 2017: -$4.46 million | Q1 2020: -$4.06 million | Q2 2020: -$4.27 million | Q3 2020: -$4.49 million | Q1 2021: -$2.25 million | Q2 2021: -$4.45 million | Q3 2021: -$6.98 million | Q1 2022: -$16.74 million | Q2 2022: -$8.62 million | Q3 2022: -$7.15 million | Q1 2023: -$11.28 million | Q2 2023: -$9.05 million | Q3 2023: -$9.36 million | Q1 2024: -$9.65 million | Q2 2024: -$7.62 million | Q3 2024: -$7.33 million | Q1 2025: -$6.06 million | Q2 2025: -$6.87 million | Q3 2025: -$7.08 million.
- Over the full 14 years of available data (2011 to 2025), SELLAS Life Sciences Group, Inc.'s Operating Income Loss has declined by 126.4%.
- Historical annual values: Fiscal year 2025: -$28.27 million | Fiscal year 2024: -$31.51 million | Fiscal year 2023: -$37.87 million | Fiscal year 2022: -$41.95 million | Fiscal year 2021: -$25.29 million | Fiscal year 2020: -$16.98 million | Fiscal year 2019: -$20.04 million | Fiscal year 2017: -$23.04 million | Fiscal year 2016: -$15.99 million | Fiscal year 2015: -$34.22 million | Fiscal year 2014: -$43.90 million | Fiscal year 2013: -$28.49 million | Fiscal year 2012: -$21.20 million | Fiscal year 2011: -$12.49 million.
- Data sourced from SEC EDGAR public filings as of August 9, 2026.
Last verified: